EHU015741
MISSION® esiRNA
targeting human TFPI2
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCTGTGGAGGGAATGACAATAACTTTGTTAGCAGGGAGGATTGCAAACGTGCATGTGCAAAAGCTTTGAAAAAGAAAAAGAAGATGCCAAAGCTTCGCTTTGCCAGTAGAATCCGGAAAATTCGGAAGAAGCAATTTTAAACATTCTTAATATGTCATCTTGTTTGTCTTTATGGCTTATTTGCCTTTATGGTTGTATCTGAAGAATAATATGACAGCATGAGGAAACAAATCATTGGTGATTTATTCACCAGTTTTTATTAATACAAGTCACTTTTTAAAAAATTTGGATTTTTTTATATATAACTAGCTGCTATTCAAATGTGAGTCTACCATTTTTAATTTATGGTTCAACTGTTTGTGAGACTGAATTCTTGCAATGCATAAGATATAAAAGCAAATATGACTCACTCATTTCTTGGGGTCGT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... TFPI2(7980)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Chiun-Wei Huang et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 34(7), 9678-9693 (2020-05-30)
Glioblastoma multiforme is the most common and aggressive glial tumor with poor prognosis. Importantly, effective treatment options for glioblastoma are unmet needs. Obesity and low physical activity have been linked with a high risk of cancer, and exercise is related
Muraly Puttabyatappa et al.
Endocrinology, 158(1), 109-120 (2016-11-05)
Increased proteolytic activity is a key event that aids in breakdown of the follicular wall to permit oocyte release. How the protease activity is regulated is still unknown. We hypothesize that tissue factor pathway inhibitor 2 (TFPI2), a Kunitz-type serine
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU015741-50UG | 04061828339044 |
| EHU015741-20UG | 04061828564521 |